Professor, Medicine, Vanderbilt University School of Medicine
Hematology
Dr. Bipin N. Savani, MD
|
|
Give Review
Bipin Savani works in the field of Hematology. He went to B. J. Medical College Ahmedabad. Bipin Savani is a published doctor. He has 101 papers published. The most current publication "Early cytomegalovirus reactivation remains associated with increased transplant related mortality in the current era: a CIBMTR analysis." Bipin Savani accepts Medicare payments and is listed with Medicare.gov.
Publications
- Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers.
- European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards.
- Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenz...
- Childhood to adult transition and long-term follow-up after blood and marrow transplantation.
- Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.
- Early cytomegalovirus reactivation remains associated with increased transplant related mortality in the current era: a CIBMTR analysis.
- When Can You Discard Stem Cells?
- Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study.
- Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.
- Autologous stem cell transplantation for adult Acute leukemia in 2015: time to rethink? Present status and future prospects.
- A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin Lymphoma.
- New Cancers after autotransplantations for multiple myeloma.
- Secondary solid Cancer screening following hematopoietic cell transplantation.
- Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors.
- Increasing incidence of Chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
- Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor Cells from unrelated donors, a Center for Inter...
- Comparison of Outcomes of Allogeneic Transplantation for CML with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan or TBI.
- Clinical and biological predictors of outcome following relapse of CML post-allo-SCT.
- Alternative donors extend transplantation for patients with Lymphoma who lack an HLA matched donor.
- Extracorporeal photopheresis as second-line treatment for Acute graft-versus-host disease: impact on six-month freedom from treatment failure.
- Long-term Survival and Late Effects among 1-year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Synd...
- High-Dose Total Body Irradiation and myeloablative Conditioning Prior to Allogeneic Stem Cell Transplantation: Time for a Rethink?
- How we manage JAK inhibition in allogeneic transplantation for myelofibrosis.
- Early Failure of Frontline Rituximab-containing Chemoimmunotherapy in Diffuse Large B-Cell Lymphoma does not Predict Futility of Autologous Hematopoietic Cell Transpla...
- Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation.
- Second solid Cancers after allogeneic hematopoietic cell transplantation using reduced intensity conditioning.
- Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blo...
- Low CD34 Dose Is Associated with Poor Survival after Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome.
- Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines of the American Society for Blood and Marrow...
- Impact of risk score calculations in choosing front-line tyrosine kinase inhibitors for patients with newly diagnosed chronic myeloid Leukemia in the chronic phase.
- Allogeneic stem cell transplantation and targeted therapy for FLT3/ITD+ Acute myeloid leukemia: an update.
- Avascular necrosis of bone after allogeneic hematopoietic Cell transplantation in children and adolescents.
- Minor RBC Ab and allo-SCT.
- Age is more than a number.
- Allotransplantation for patients age 40 years and greater with non-Hodgkin Lymphoma (NHL): encouraging progression-free survival.
- Outcomes of hematopoietic cell transplantation for diffuse large B cell Lymphoma transformed from follicular Lymphoma.
- Preparative Regimen Dosing for Hematopoietic Stem Cell Transplantation in Patients with Chronic Kidney Disease: Analysis of the Literature and Recommendations.
- Expression of putative targets of immunotherapy in Acute myeloid leukemia and healthy tissues.
- Preparative Regimen Dosing for Hematopoietic Stem Cell Transplantation in Patients with Chronic Hepatic Impairment: Analysis of the Literature and Recommendations.
- Conditioning regimens in allo-SCT for thalassemia major.
- Management of relapses after hematopoietic cell transplantation in T-cell non-Hodgkin Lymphomas.
- Reduced-intensity hematopoietic Cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow tran...
- Clinical guide to fertility preservation in hematopoietic Cell transplant recipients.
- Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good Cancer after all!
- Conditioning Chemotherapy Dose Adjustment in Obese Patients: A Review and Position Statement by the American Society for Blood and Marrow Transplantation Practice Guid...
- Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
- Response to "What Is the Optimal Approach to Major ABO-Incompatible Allogeneic Stem Cell Transplantation".
- Repair of Impaired Pulmonary Function Is Possible in Very-Long-Term Allogeneic Stem Cell Transplantation Survivors.
- Effect of post remission therapy prior to reduced intensity conditioning allogeneic transplantation for Acute myeloid leukemia in first complete remission.
- Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin Lymphoma.
- Male Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Have a Long Term Persisting Risk of Cardiovascular Events.
- Six-month freedom from treatment failure is an important end point for Acute GVHD clinical trials.
- New allergies after cord blood transplantation.
- Geographic Distance Is Not Associated with Inferior Outcome When Using Long-Term Transplant Clinic Strategy.
- Providing Personalized Prognostic Information for Adult Leukemia Survivors.
- Better Leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared to TBI.
- Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma.
- Umbilical cord blood transplant: expanding the options.
- Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhi...
- Building a transplant physician workforce for growing need: Recruitment starts during residency.
- Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid refractory Acute GVHD: A multicenter comparative analysis.
- Long-term follow-up of informal caregivers after allo-SCT: a Systematic review.
- Unrelated donor allogeneic transplantation after failure of autologous transplantation for Acute myeloid leukemia: a study from the cibmtr.
- Clinical Guide to ABO Incompatible Allogeneic Stem Cell Transplantation.
- Second malignancies after autologous hematopoietic Cell transplantation in children.
- Impact of Pretransplantation Conditioning Regimens on Outcomes of Allogeneic Transplantation for Chemotherapy-Unresponsive Diffuse Large B Cell Lymphoma and Grade III ...
- Salvage Second Hematopoietic Cell Transplantation in Myeloma.
- Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell Lymphoma: a cohort analysis from the center for international blood and marrow ...
- Minimal residual Disease in myeloma: are we there yet?
- Tissue-specific regulatory T cells; biomarker for Acute graft-versus-host disease and survival.
- Time to Explore Preventive and Novel Therapies for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.
- Predicting post-transplant diabetes mellitus by regulatory T Cell phenotype: implications for metabolic intervention to modulate alloreactivity.
- Female long-term survivors after allogeneic hematopoietic stem Cell transplantation: evaluation and management.
- Management of high ferritin in long-term survivors after hematopoietic stem Cell transplantation.
- How can we improve life expectancy and quality of life in long-term survivors after allogeneic stem Cell transplantation?
- Lymphodepletion is permissive to the development of spontaneous T-Cell responses to the self-antigen PR1 early after allogeneic stem Cell transplantation and in patien...
- Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic Cell transplantation for hematological malignancies.
- Classifying Cytogenetics in Patients with AML in Complete Remission Undergoing Allogeneic Transplantation: A CIBMTR Study.
- Selectively T Cell-Depleted AlloGrafts from HLA-Matched Sibling Donors Followed by Low-Dose Posttransplant Immunosuppression to Improve Transplant Outcome in Patients ...
- Genetic variation in recipient B-Cell activating factor modulates phenotype of GVHD.
- Evolution of the donor T-Cell repertoire in recipients in the second decade after allogeneic stem Cell transplantation.
- Treatment Options for Transformed Lymphoma: Incorporating Allogeneic Stem Cell Transplantation in a Multimodality Approach.
- Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients.
- How I treat late effects in adults after allogeneic stem Cell transplantation.
- Pregnancy after hematopoietic Cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Resear...
- Pretransplantation C-Peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem Cell transplantation.
- Transplantation in AML CR1.
- Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for Acute myeloid leu...
- Dyslipidemia after allogeneic hematopoietic stem Cell transplantation: evaluation and management.
- Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem Cell transplantation for hematologic malignancies.
- Time to consider HPV vaccination after allogeneic stem Cell transplantation.
- Classic and overlap Chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP).
- Lamivudine prophylaxis and hepatitis B vaccination for prevention of hepatitis B virus reverse seroconversion in long-term survivors after allogeneic stem Cell transpl...
- Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?
- Prophylactic intravenous immunoglobulin does not have a role in hematopoietic stem-Cell transplantation: is the evidence clear?
- Does extra alemtuzumab remove the graft-versus-Leukemia effect after allogeneic stem cell transplantation in chronic lymphocytic Leukemia?
- Can routine posttransplant HPV vaccination prevent commonly occurring epithelial Cancers after allogeneic stem cell transplantation?
- Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with Acute lymphoblastic leukemia and Acute and chronic myel...
- Prolonged Chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hemat...
- Primitive quiescent CD34+ cells in chronic myeloid Leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib.
Schools
Bj Medical College Ahmedabad Gujarat University
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Carcinoma in Situ
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
National Institutes of Health Clinical Center -
University of Massachusetts -
B. J. Medical College Ahmedabad
Hospital
-
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1801086665 | |
| NPPES Provider LastName | SAVANI | |
| NPPES Provider FirstName | BIPIN | |
| NPPES Provider ZIPCode | 372122637 | |
| NPPES Provider State | TN | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 140.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801086665 |
| Last Name Of The Provider | SAVANI |
| First Name Of The Provider | BIPIN |
| View All |
Similar Doctors
|
|
Dr. William C. Penley, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Madan Jagasia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wichai Chinratanalab, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mia A. Levy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Doukas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Taber, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Laura W. Goff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laquisa C. Hill, MD |
|
|
Dr. Sanford B. Krantz, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Valerie M. Jansen, MD |
|
|
Dr. David Head, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew J. Rioth, MD |
|
|
Ojiugo M. Iko, MB
This Doctor is OpenDoctor Recommended.
|